New Products Launch at Pittcon 2015

New Products Launch at Pittcon 2015

March 09, 2015

Trajan Scientific and Medical has unveiled new SGE products at Pittcon 2015 in New Orleans, Louisiana, USA.

Unable to visit Trajan at Pittcon Booth #2129 from March 9 - 12?

Explore each new product page for more information:

MyCapLC™ Kit for Life Sciences
Customize CapLC for Your Application
• DIY capillary column packing, no special instrumentation required.
• Make the column that you want.
• Perfect for your life sciences analysis.

PEEKTite™ Ti-Lok EXP UHPLC Fittings
Uncomplicated and Reliable UHPLC Connections
• Finger tight nut and ferrule system designed for use with PEEKsil tubing.
• Holds up to 18,000 psi (1,240 bar).
• Compatible with any 6-32 and 6-40 port configuration.

 

ProteCol® Bio-Inert UHPLC Column Hardware
Smooth and Inert Glass Lining for Optimal UHPLC Bio Applications
• Improved column performance for bio applications.
• Designed for continuous use at 20,000 psi (1,379 bar).
• Demonstrate the performance of your phase.




Also in News

Government supports expansion of Trajan's Victorian facility
Government supports expansion of Trajan's Victorian facility

April 17, 2019

Trajan Scientific and Medical welcomed Minister for Jobs, Innovation and Trade, Martin Pakula at Trajan’s global corporate headquarters in Melbourne today to announce a grant supporting advanced scientific manufacturing in Victoria.

Read More

Trajan announces acquisition of Soltec Inc
Trajan announces acquisition of Soltec Inc

December 06, 2018

Trajan Scientific and Medical today announced the acquisition of the business of Soltec Inc, located in Bethel CT, USA.

Read More

Trajan invests in personalized therapeutic technologies center
Trajan invests in personalized therapeutic technologies center

November 21, 2018

Trajan Scientific and Medical is pleased to be part of launching the ARC Centre for Personalised Therapeutics Technologies (ARC CPTT) today in Melbourne, Australia. The center aims to provide a world-leading commercial advantage in developing therapeutic treatments.

Read More